Long-term prognostic significance of HER2-low and HER2-zero in node-negative breast cancer.
Almstedt K, Heimes AS, Kappenberg F, Battista MJ, Lehr HA, Krajnak S, Lebrecht A, Gehrmann M, Stewen K, Brenner W, Weikel W, Rahnenführer J, Hengstler JG, Hasenburg A, Schmidt M.
Almstedt K, et al. Among authors: weikel w.
Eur J Cancer. 2022 Sep;173:10-19. doi: 10.1016/j.ejca.2022.06.012. Epub 2022 Jul 12.
Eur J Cancer. 2022.
PMID: 35839597